Does Montelukast Increase the Risk for Neuropsychiatric Disease?
Children with asthma who received montelukast had no increased risk for neuropsychiatric disease compared with children who did not receive the treatment.
Psychosis
Some Characteristics Unique to Depression Before, After Birth
Background traits tied to chronic depression; delivery experience tied to early postpartum depression.
Psychopathic Traits in Adulthood Up With Child Lead Exposure
Higher childhood blood lead levels are associated with more psychopathy during the life course, according to a new study published in JAMA.
Benzodiazepine, Opioid Co-Usage Up in the United States
Concurrent use of benzodiazepine receptor modulators and opioids and of nonselective and selective benzodiazepine receptor modulators increased from 1999-2000 to 2013-2014.
Review Gives Guidance to Support Teens With Gender Dysphoria
Primary care providers are well positioned to provide critical support and personalized care for youth with gender dysphoria and their caregivers or families, according to a review published online January 21 in CMAJ, the journal of the Canadian Medical Association.
Wearable Sensor Data Help ID Children With Internalizing Dx
Wearable sensor data extracted from a fear induction task paired with machine learning can accurately identify young children with internalizing diagnosis.
Mindfulness, Stress Linked to Menopausal Symptoms
Higher mindfulness and lower stress are independently associated with lower menopausal symptom scores among midlife women.
Assessing Symptoms After 4 Weeks of Psychotherapy Helpful in Teens
Therapists implementing interpersonal psychotherapy for depressed adolescents (IPT-A) should routinely monitor depression symptoms and consider augmenting treatment for insufficient responders as early as week 4 of treatment.
FDA: Important Updates to the Clozapine REMS Program
Products covered under the Clozapine REMS program include Clozaril (HLS Therapeutics), Fazaclo (Jazz), and Versacloz (TruPharma), in addition to all generic versions.
Drug Repurposing May Provide More Psychiatric Tx Options
Three classes of drugs hold potential as repurposed agents to treat patients with serious mental illness, according to a study published online January 9 in JAMA Psychiatry.
